Correction to: Association of traditional cardiovascular risk factors with venous thromboembolism: An individual participant data meta-Analysis of prospective studies (Circulation (2017) 135 (7-16) DOI: 10.1161/CIRCULATIONAHA.116.024507);Association of traditional cardiovascular risk factors with venous thromboembolism

Circulation

Volumn 135, Issue 1, 2017, Pages 7-16

  Mahmoodi, Bakhtawar K ^a,b   Cushman, Mary ^c   Næss, Inger Anne ^d   Allison, Matthew A ^e   Bos, Willem Jan ^a   Brækkan, Sigrid K ^f   Cannegieter, Suzanne C ^g   Gansevoort, Ron T ^b   Gona, Philimon N ^h   Hammerstrøm, Jens ^d   Hansen, John Bjarne ^f   Heckbert, Susan ⁱ   Holst, Anders G ^j   Lakoski, Susan G ^k   Lutsey, Pamela L ^l   Manson, JoAnn E ^m   Martin, Lisa W ⁿ   Matsushita, Kunihiro ^o   Meijer, Karina ^b   Overvad, Kim ^p,q   Prescott, Eva ^r   Puurunen, Marja ^s   Rossouw, Jacques E ^t   Sang, Yingying ^o   Severinsen, Marianne T ^q   Ten Berg, Jur ^a   Folsom, Aaron R ^l   Zakai, Neil A ^c   more..

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF VERMONT   (United States)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TROMSØ   (Norway)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j University of Copenhagen   (Denmark)

^k UNIVERSITY OF TEXAS   (United States)

^l UNIVERSITY OF MINNESOTA   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^o JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^p AARHUS UNIVERSITY   (Denmark)

^q AALBORG UNIVERSITY HOSPITAL   (Denmark)

^r UNIVERSITY OF COPENHAGEN   (Denmark)

^s FRAMINGHAM HEART STUDY   (United States)

^t NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

cardiovascular disease; diabetes mellitus; hyperlipidemia; hypertension; risk factors; smoking; venous thromboembolism

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; SENSITIVITY ANALYSIS; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD PRESSURE; COMPLICATION; DIABETIC COMPLICATION; PROPORTIONAL HAZARDS MODEL; PULMONARY EMBOLISM; RISK FACTOR; SEX DIFFERENCE; VENOUS THROMBOSIS;

LIPID;

AGE FACTORS; BLOOD PRESSURE; BODY MASS INDEX; DIABETES COMPLICATIONS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIPIDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; SEX FACTORS; SMOKING; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84996866012     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000497     Document Type: Erratum

References (31)

1. Beckman MG, Hooper WC, Critchley SE, Ortel TL, Venous thromboembolism: a public health concern. Am J Prev Med 2010 38 4 Suppl S495 S501. doi: 10.1016/j.amepre.2009.12.017.
2. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M, VTE Impact Assessment Group in Europe (VITAE) Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 2007 98 756 764
3. Rosendaal FR, Risk factors for venous thrombotic disease. Thromb Haemost 1999 82 610 619
4. White RH, The epidemiology of venous thromboembolism. Circulation 2003 107 23 Suppl 1 I4 I8. doi: 10.1161/01.CIR.0000078468.11849.66.
5. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 Suppl 2 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98.
6. Prandoni P, Venous thromboembolism and atherosclerosis: is there a link? J Thromb Haemost 2007 5 Suppl 1 270 275. doi: 10.1111/j.1538-7836.2007.02467.x.
7. Holst AG, Jensen G, Prescott E, Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010 121 1896 1903. doi: 10.1161/CIRCULATIONAHA.109.921460.
8. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW, Cardiovascular risk factors and venous thromboembolism: a meta-Analysis. Circulation 2008 117 93 102. doi: 10.1161/CIRCULATIONAHA.107.709204.
9. Gariani K, Mavrakanas T, Combescure C, Perrier A, Marti C, Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-Analysis of case-control and cohort studies. Eur J Intern Med 2016 28 52 58. doi: 10.1016/j.ejim.2015.10.001.
10. Bai J, Ding X, Du X, Zhao X, Wang Z, Ma Z, Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-Analysis. Thromb Res 2015 135 90 95. doi: 10.1016/j.thromres.2014.11.003.
11. Bell EJ, Folsom AR, Lutsey PL, Selvin E, Zakai NA, Cushman M, Alonso A, Diabetes mellitus and venous thromboembolism: a systematic review and meta-Analysis. Diabetes Res Clin Pract 2016 111 10 18. doi: 10.1016/j.diabres.2015.10.019.
12. Cheng YJ, Liu ZH, Yao FJ, Zeng WT, Zheng DD, Dong YG, Wu SH, Current and former smoking and risk for venous thromboembolism: a systematic review and meta-Analysis. PLoS Med 2013 10 e1001515. doi: 10.1371/journal.pmed.1001515.
13. Brækkan SK, Hald EM, Mathiesen EB, Njølstad I, Wilsgaard T, Rosendaal FR, Hansen JB, Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol 2012 32 487 491. doi: 10.1161/ATVBAHA.111.237545.
14. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, van der Meer J, Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group Microalbuminuria and risk of venous thromboembolism. JAMA 2009 301 1790 1797. doi: 10.1001/jama.2009.565.
15. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR, Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002 162 1182 1189
16. Wattanakit K, Lutsey PL, Bell EJ, Gornik H, Cushman M, Heckbert SR, Rosamond WD, Folsom AR, Association between cardiovascular disease risk factors and occurrence of venous thromboembolism: a time-dependent analysis. Thromb Haemost 2012 108 508 515. doi: 10.1160/TH11-10-0726.
17. Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn RJ, Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J Thromb Haemost 2012 10 189 198. doi: 10.1111/j.1538-7836.2011.04588.x.
18. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM, A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009 360 1851 1861. doi: 10.1056/NEJMoa0900241.
19. Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, Fodor G, Held C, Micks M, Genest J Jr, HOPE-2 investigators Venous thromboembolism in association with features of the metabolic syndrome. QJM 2007 100 679 684. doi: 10.1093/qjmed/hcm083.
20. Rosengren A, Fredén M, Hansson PO, Wilhelmsen L, Wedel H, Eriksson H, Psychosocial factors and venous thromboembolism: a long-Term follow-up study of Swedish men. J Thromb Haemost 2008 6 558 564. doi: 10.1111/j.1538-7836.2007.02857.x.
21. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013 310 1353 1368. doi: 10.1001/jama.2013.278040.
22. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J, Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007 5 692 699. doi: 10.1111/j.1538-7836.2007.02450.x.
23. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K, Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009 120 1850 1857. doi: 10.1161/CIRCULATIONAHA.109.863241.
24. Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL, Cushman M, Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 2014 129 1502 1509. doi: 10.1161/CIRCULATIONAHA.113.006472.
25. Puurunen MK, Enserro D, Xanthakis V, Larson MG, Benjamin EJ, Tofler GH, Wollert KC, O'Donnell CJ, Vasan RS, Biomarkers for the prediction of venous thromboembolism in the community. Thromb Res 2016 145 34 39. doi: 10.1016/j.thromres.2016.07.006.
26. Lutsey PL, Virnig BA, Durham SB, Steffen LM, Hirsch AT, Jacobs DR Jr, Folsom AR, Correlates and consequences of venous thromboembolism: the Iowa Women's Health Study. Am J Public Health 2010 100 1506 1513. doi: 10.2105/AJPH.2008.157776.
27. Enga KF, Braekkan SK, Hansen-Krone IJ, le Cessie S, Rosendaal FR, Hansen JB, Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost 2012 10 2068 2074. doi: 10.1111/j.1538-7836.2012.04880.x.
28. Quist-Paulsen P, Naess IA, Cannegieter SC, Romundstad PR, Christiansen SC, Rosendaal FR, Hammerstrøm J, Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica 2010 95 119 125. doi: 10.3324/haematol.2009.011866.
29. Wojewódzka-Zelezniakowicz M, Chabielska E, Mogielnicki A, Kramkowski K, Karp A, Opadczuk A, Domaniewski T, Malinowska-Zaprzałka M, Buczko W, Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats. J Physiol Pharmacol 2006 57 231 245
30. Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA, Statistical analysis of individual participant data meta-Analyses: a comparison of methods and recommendations for practice. PLoS One 2012 7 e46042. doi: 10.1371/journal.pone.0046042.
31. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB, Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study. J Thromb Haemost 2008 6 1851 1857. doi: 10.1111/j.1538-7836.2008.03102.x.